Liraglutide studies
7,821 journal papers mention Liraglutide in the title or abstract. Here are the most cited, the latest, and a few facts about the literature.
Studies range from laboratory work to clinical trials. A paper listed here is not an endorsement and says nothing about whether Liraglutide is safe, effective or approved for any use.
- Papers
- 7,821
- 6,501 articles, 1,320 reviews
- Earliest paper
- 1985
- Most papers in 2025 (882)
- Open access
- 59%
- free to read somewhere
- Reviews
- 17%
- of all papers listed
What kind of studies
Of 5,713 papers in PubMed that mention Liraglutide in the title or abstract, by the study type PubMed records. Categories overlap, so they do not add up to the total.
- Randomized controlled trials561
- Other clinical trials55
- Meta-analyses and systematic reviews415
- Other reviews1,660
- Case reports172
- Animal studies only829
- Studies in humans3,460
Study types are tags assigned by publishers and PubMed indexers; very new papers are often not tagged yet, and a tag is not a quality rating. Retracted papers are excluded. Source: PubMed (NCBI).
Registered clinical studies
Studies on ClinicalTrials.gov that mention Liraglutide in their intervention details. A registration says a study is planned or running, not what it found.
- Registered
- 520
- Completed
- 368
- Ongoing or planned
- 47
- Phase 1
- 72
- Phase 2
- 79
- Phase 3
- 113
- The Effect of Liraglutide on Body Weight, Body Composition, Ectopic Lipid Accumulation and Insulin Sensitivity in Subjects With Overweight or Obesity Without Diabetes
NCT07913685CompletedPhase 4started 2023-04-05
- Changes in Body Composition Following Pharmacological Treatment for Obesity.
NCT07908940Enrolling by invitationstarted 2025-09-01
- A Study on the Safety and Clinical Efficacy of Guominkang in the Treatment of Diabetic Kidney Disease
NCT07907965Active, not recruitingPhase 2started 2025-10-20
- A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics
NCT04466566CompletedPhase 3started 2022-10-17
- Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With Obesity
NCT07901777Recruitingstarted 2026-09-15
The five most recently updated studies. See all 520 on ClinicalTrials.gov. Source: ClinicalTrials.gov (U.S. National Library of Medicine). Studies are found by the compound's name, so a few may be about something else.
Papers per year
1997 to 2026, peak 882 papers in a year. The latest year may still be incomplete.
Where it is published
- Diabetes328 papers
- Diabetes Obesity and Metabolism323 papers
- Diabetes Care106 papers
- Diabetes Therapy102 papers
- Value in Health90 papers
The papers
Most citedName in the title
- The Discovery and Development of Liraglutide and Semaglutide
Lotte Bjerre Knudsen, Jesper F. Lau · Frontiers in Endocrinology · 2019
ReviewOpen access · CC BY971 citationsRead the open copy →
LatestName in title or abstract
- EMERGING PHARMACOLOGICAL STRATEGIES IN OBESITY: FROM GLP-1 AGONISTS THROUGH TRIPLE INCRETIN THERAPY TO AMYLIN ANALOGS – NARRATIVE REVIEW
Dagmara Laufer, Olga Klimczak, Filip Chodań et al. · Archiv Euromedica · 2026
ReviewOpen accessRead the open copy →
- Systematic review of the neuroprotective potential of GLP1 receptor agonists and SGLT2 inhibitors in Alzheimer’s disease and cognitive impairment
Marwa A. Dewer, Salma G. Dawod, Nada M. Elbadawy et al. · Discover Neuroscience · 2026
ReviewOpen access · CC BYRead the open copy →
- GLP‐1–Based Therapy in Type 1 Diabetes: Balancing Efficacy, Safety, and Patient Selection
Thales Rossatto, Ricardo de Andrade Oliveira, Andréia Machado Cardoso · Diabetes Obesity and Metabolism · 2026
ReviewOpen access · CC BYRead the open copy →
- Efficacy and safety of GLP-1 receptor agonists for antipsychotic-related overweight and metabolic dysregulation: a systematic review and meta-analysis
Lingyan Zhou, Ying Zhang, Chao Shen et al. · European Journal of Clinical Pharmacology · 2026
Meta-analysis
- Skeletal effects of GLP-1 receptor agonist therapy in adults with overweight or obesity: a systematic review
Cheng-Hao Lai, YU-TZU LI, Ting-Shuan Wu et al. · Archives of Osteoporosis · 2026
Systematic review
- How Well Are We Measuring Nausea? A Narrative Review of Patient‐Reported Outcome Gaps in GLP ‐1 Receptor Agonist Obesity Trials
Lima Oria, Mohammad Darkhabani · Diabetes Obesity and Metabolism · 2026
Review
- Emerging Therapeutic Strategies for Child and Adolescent Obesity: A Narrative Review
Tomaso Oliaro, Amianto Federico · Nutrients · 2026
ReviewOpen access · CC BYRead the open copy →
- Impact of Metabolic Syndrome, Type 2 Diabetes Mellitus, and Metabolic Pharmacotherapies on the Progression of MASLD/MASH to Advanced Fibrosis and Cirrhosis: A Systematic Review
Isabela Bullara Mirandola, ANA THAIS PIRES ALVES, Damaris Fonseca Peixoto Silva et al. · Archives of Gastroenterology Research · 2026
ReviewOpen accessRead the open copy →
Each list shows up to 40 papers.See all 7,821 on OpenAlex. Source: OpenAlex (CC0), journal articles and reviews with a DOI, retractions excluded, refreshed weekly, last 4 Nov 2026, 08:31 UTC. Papers are listed by their metadata only; follow the links to read them. A license shown on an open copy is the license the publisher or repository states for that copy.